-
China, Saudi Arabia sign MoU on drug regulation
2024-11-12
Li Li, commissioner of China's National Medical Products Administration (NMPA), signed a memorandum of understanding (MoU) on cooperation with Hisham S Aljadhey, chief executive officer of the Saudi Food and Drug Authority (SFDA), on Nov 1 in Beijing, to further enhance bilateral exchanges and cooperation in drug regulation.
-
NMPA signs letter of intent on cooperation with Danish Medicines Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices in Beijing on Oct 24.
-
Li Li meets with head of Brazil’s Health Regulatory Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Antonio Barra Torres, head of Brazil's Health Regulatory Agency (Anvisa), in Beijing on Oct 21.
-
China plans credit system to curb medical insurance misuse
2024-09-29
China issued a guideline on Friday on developing a credit system for hospital and pharmacy personnel certified to process medical insurance funds in order to strengthen supervision.
-
Big push for homegrown innovative medicines
2024-09-27
The National Medical Products Administration, China's top drug regulator, says it will redouble efforts to facilitate research and market registration of homegrown innovative drugs, while speeding up the introduction of novel foreign drugs to the domestic market to meet public demand.
-
Huang Guo meets with Danish ambassador to China
2024-09-20
On Sept 10, Huang Guo, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Michael Starbaek Christensen, Danish ambassador to China.
